title: Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.
authors.forename: H
authors.initials: H
authors.lastname: Herfarth
authors.forename: C
authors.initials: C
authors.lastname: Tjaden
authors.forename: M
authors.initials: M
authors.lastname: Lukas
authors.forename: F
authors.initials: F
authors.lastname: Obermeier
authors.forename: K
authors.initials: K
authors.lastname: Dilger
authors.forename: R
authors.initials: R
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Schölmerich
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D019804:Mesalamine / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D001379:Azathioprine